MedPath

European Organisation For Research & Treatment Of Cancer

🇬🇧United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.eortc.be

Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM

Phase 2
Active, not recruiting
Conditions
Malignant Pleural Mesothelioma
Interventions
Procedure: pleurectomy/decortication
Drug: Pemetrexed/Cisplatin
First Posted Date
2015-05-07
Last Posted Date
2022-11-07
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
64
Registration Number
NCT02436733
Locations
🇳🇱

Erasmus MC Hospital, Rotterdam, Netherlands

🇧🇪

UZ Antwerpen, Antwerpen, Belgium

🇳🇱

The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam, Netherlands

and more 1 locations

Evaluation of Diffusion Weighted Imaging -MRI in Patients With Resectable Liver Metastases From Colorectal Cancer

Not Applicable
Conditions
Liver Metastases
Colorectal Cancer
First Posted Date
2015-02-04
Last Posted Date
2015-02-04
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
31
Registration Number
NCT02355353

SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access

Withdrawn
Conditions
Brain Neoplasms
Interventions
Genetic: Tumour markers testing
First Posted Date
2014-12-04
Last Posted Date
2019-06-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Registration Number
NCT02307604
Locations
🇫🇷

CHRU de Lille, Lille, France

🇫🇷

Assistance Publique - Hopitaux de Paris - La Pitie Salpetriere, Paris, France

Randomized Boost Versus no Boost Irradiation of Early Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Interventions
Radiation: Boost irradiation
First Posted Date
2014-11-19
Last Posted Date
2014-11-19
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Registration Number
NCT02295033

Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo

Not Applicable
Conditions
Non-small Cell Lung Carcinoma
Interventions
Other: 18F-FLT-PET/CT and DWI-MRI
First Posted Date
2014-10-23
Last Posted Date
2015-10-30
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
31
Registration Number
NCT02273271
Locations
🇮🇹

Istituto Clinico Humanitas, Milano, Italy

🇬🇧

Royal Marsden Hospital - Sutton, Surrey, Sutton, United Kingdom

Trabectedin for Recurrent Grade II/III Meningioma

Phase 2
Completed
Conditions
Recurrent High Grade Meningioma
Interventions
Other: Local standard of care
First Posted Date
2014-09-09
Last Posted Date
2019-02-28
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
90
Registration Number
NCT02234050
Locations
🇦🇹

Landesnervenklinik Wagner Jauregg, Linz, Austria

🇧🇪

U.Z. Leuven - Campus Gasthuisberg, Leuven, Belgium

🇧🇪

CHU Dinant Godinne - UCL Namur, Yvoir, Belgium

and more 44 locations

A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program

Completed
Conditions
Liver Metastasis
Colorectal Carcinoma
Interventions
Other: Evaluation of treatment for liver metastasis
First Posted Date
2014-08-18
Last Posted Date
2022-05-31
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
219
Registration Number
NCT02218801
Locations
🇦🇹

Innsbruck Universitaetsklinik, Innsbruck, Austria

🇦🇹

Der Wiener Krankenanstaltenverbund - Krankenanstalt Rudolfstiftung, Vienna, Austria

🇳🇱

Leiden University Medical Centre, Leiden, Netherlands

and more 13 locations

Ph II CABOGIST in GIST

Phase 2
Completed
Conditions
Metastatic Gastrointestinal Stromal Tumor
Interventions
First Posted Date
2014-08-15
Last Posted Date
2021-07-15
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
51
Registration Number
NCT02216578
Locations
🇫🇷

Institut Bergonie (228), Bordeaux, France

🇨🇿

University Hospital Motol (1905), Prague, Czechia

🇫🇷

Centre Leon Berard (227), Lyon, France

and more 8 locations

SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access

Completed
Conditions
Any Stage of Any Thymic Malignancy
Any Stage of Lung Cancer (Any Histotype)
Any Stage of Malignant Pleural Mesothelioma
Interventions
Genetic: Tumour markers testing
First Posted Date
2014-08-12
Last Posted Date
2022-07-08
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
539
Registration Number
NCT02214134
Locations
🇫🇷

CHU de Lyon - Hopital Louis Pradel, Lyon, France

🇧🇪

U.Z. Leuven - Campus Gasthuisberg, Leuven, Belgium

🇮🇹

Ospedale S. Luigi Gonzaga - Universita Di Torino, Torino, Italy

and more 14 locations

Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma

Phase 2
Completed
Conditions
Epidermal Growth Factor Receptor (EGFR) Protein Overexpression
Malignant Neoplasm of Stomach
Malignant Neoplasm of Cardio-esophageal Junction of Stomach
Interventions
First Posted Date
2014-07-31
Last Posted Date
2025-02-26
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
171
Registration Number
NCT02205047
Locations
🇧🇪

University Hospital Gent, Gent, Vlaanderen, Belgium

🇵🇹

Instituto Portugues De Oncologia - Centro Do Porto, Porto, Portugal

🇪🇪

North Estonia Medical Centre, Tallinn, Estonia

and more 40 locations
© Copyright 2025. All Rights Reserved by MedPath